Consensus Johnson & Johnson

Equities

JNJ

US4781601046

Real-time Estimate Cboe BZX 12:24:08 2024-03-28 pm EDT 5-day change 1st Jan Change
158.5 USD +0.31% Intraday chart for Johnson & Johnson +1.86% +1.21%

Evolution of the average Target Price on Johnson & Johnson

Price target over the last 5 years

History of analyst recommendation changes

2aac0548aa831eed837548f9.d87_dM2XbUHB_tbTNNic6riDtMpYIsdxjdOcOHzC5GQ.Ia-VLKL7JwaRipewVZOxhcu757AvWIww1KH1aE6BrVRFq6VNheRANriRsQ~090a4526f70aa8871af053e056833d4a
Guggenheim Trims Price Target on Johnson & Johnson to $167 From $169, Maintains Neutral Rating MT
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $170, Maintains Equalweight Rating MT
The market awaits the BCE meeting and earnings reports Our Logo
The start of a new bull market? Our Logo
B. Riley Downgrades Ambrx Biopharma to Neutral From Buy on Heels of Announced Sale to Johnson & Johnson, Adjusts PT to $28 From $26 MT
Raymond James Raises Johnson & Johnson's Price Target to $175 From $172, Maintains Outperform Rating MT
ANALYST RECOMMENDATIONS : Adobe, Airbnb, Netflix, Nike, Etsy... Our Logo
Wells Fargo Downgrades Johnson & Johnson to Equalweight From Overweight, Cuts Price Target to $163 From $170 MT
Morgan Stanley Trims Price Target on Johnson & Johnson to $170 From $171, Keeps Equalweight Rating MT
Job losses delight investors Our Logo
RBC Raises Price Target on Johnson & Johnson to $181 From $178, 'Encouraged' by Enterprise Business Review, Keeps Outperform Rating MT
UBS Upgrades Johnson & Johnson to Buy From Neutral, Raises Price Target to $180 From $167 MT
J&J : Wells Fargo remains positive, lowers target CF
EMEA Morning Briefing: Cooling U.S. Inflation Fuels Hopes That Rates Have Peaked DJ
Diageo gets price target cuts; JPMorgan ups M&G AN
ANALYST RECOMMENDATIONS : Dollar General, On Holding, Rio Tinto, Solaredge, Thermo Fisher... Our Logo
ANALYST RECOMMENDATIONS : Best Buy, Easyjet, Fortinet, Tesla, Netflix... Our Logo
UBS Raises Johnson & Johnson Price Target to $167 From $165, Maintains Neutral Rating MT
Raymond James Adjusts Price Target on Johnson & Johnson to $172 From $179, Keeps Outperform Rating MT
Morgan Stanley Lowers Price Target on Johnson & Johnson to $171 From $174, Keeps Equalweight Rating MT
Wells Fargo Cuts Price Target on Johnson & Johnson to $178 From $186, Keeps Overweight Rating MT
Rate hike fears return with a vengeance Our Logo
TSX futures fall ahead of domestic CPI data RE
UBS Lowers Price Target on Johnson & Johnson to $165 From $177, Keeps Neutral Rating MT
Middle East and earnings season disrupt the market Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
158 USD
Average target price
175.4 USD
Spread / Average Target
+11.05%
High Price Target
215 USD
Spread / Highest target
+36.11%
Low Price Target
160 USD
Spread / Lowest Target
+1.29%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Johnson & Johnson

Guggenheim
Morgan Stanley
Raymond James
Wells Fargo Securities
RBC Capital Markets
UBS
HSBC
Atlantic Equities
Barclays
Stifel Nicolaus
JPMorgan Chase
Credit Suisse
Bernstein
SVB Securities LLC
Citigroup
Goldman Sachs
DA Davidson
SVB Financial
Daiwa Securities
Sanford Bernstein
Cantor Fitzgerald
J.P. Morgan Chase
Cowen
SVB Leerink
RBC Brandon Henry
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock
  2. Equities
  3. Stock Johnson & Johnson - Nyse
  4. Consensus Johnson & Johnson